CN209500067U - A kind of analgesic dressing inhibiting scar - Google Patents
A kind of analgesic dressing inhibiting scar Download PDFInfo
- Publication number
- CN209500067U CN209500067U CN201821456715.8U CN201821456715U CN209500067U CN 209500067 U CN209500067 U CN 209500067U CN 201821456715 U CN201821456715 U CN 201821456715U CN 209500067 U CN209500067 U CN 209500067U
- Authority
- CN
- China
- Prior art keywords
- layer
- dressing
- wound
- absorbable
- analgesic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 231100000241 scar Toxicity 0.000 title claims abstract description 33
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 16
- 230000000202 analgesic effect Effects 0.000 title claims abstract description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 18
- 239000010703 silicon Substances 0.000 claims abstract description 18
- 230000001139 anti-pruritic effect Effects 0.000 claims abstract description 10
- 239000003908 antipruritic agent Substances 0.000 claims abstract description 10
- -1 polytetrafluoroethylene Polymers 0.000 claims description 4
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 229920001308 poly(aminoacid) Polymers 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229920002545 silicone oil Polymers 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 244000003416 Asparagus officinalis Species 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- 210000004508 polar body Anatomy 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 18
- 208000027418 Wounds and injury Diseases 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 7
- 230000029663 wound healing Effects 0.000 abstract description 5
- 206010020718 hyperplasia Diseases 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 12
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 241000234427 Asparagus Species 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000002260 Keloid Diseases 0.000 description 2
- 206010023330 Keloid scar Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000001117 keloid Anatomy 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 241001116389 Aloe Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005297 material degradation process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- LGERWORIZMAZTA-UHFFFAOYSA-N silicon zinc Chemical compound [Si].[Zn] LGERWORIZMAZTA-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
The utility model relates to a kind of analgesic dressings for inhibiting scar, are made of antipruritic layer, silicon gel layer, electret layer, dressing layer, adhered layer and peeling layer；The electret layer be it is inverted U-shaped, empty portions are filled by the silicon gel layer；The bottom end of the electret layer and silicon gel layer is concordant, and is completely covered by the dressing layer.It is novel that the structure design of the utility model is reasonable, on the one hand, mainly can play protective effect by dressing layer in the wound healing stage, can slow down wound by electret layer and give patient's bring pain；On the other hand, as dressing layer is gradually degraded and absorbed, the surface of a wound heals therewith, so that the silicon gel layer being exposed be made to play the effect for inhibiting scar hyperplasia.Therefore, which can remove the worry that general wound needs frequent care following from, effectively protect to the surface of a wound, to be more conducive to the healing of wound, improve comfort and reduce the generation of scar.
Description
Technical field
The utility model relates to a kind of medical macromolecular materials products, and in particular to a kind of analgesic dressing for inhibiting scar.
Background technique
In daily life, everyone inevitably reels, and leaves wound.And wound is usually associated with violent feeling of pain,
The wound of healing can also leave scar, influence beauty.For the people of scar constitution, scar not only will form after wound healing,
These scars can also be raised next, or even spreads to surrounding, more longer bigger, forms keloid.Keloid is substantially scar
Histiocytic misgrowth is a kind of out of control growth.
At present there are many kinds of the methods for the treatment of scar, scar cream is mainly smeared, pressure garment, shallow-layer radiotherapy is worn, injects and control
Treatment, laser therapy and operative treatment etc..These methods respectively have advantage and disadvantage, still can achieve perfect effect without any method
Fruit.And part scar shows as the tissue color purple, is higher than normal skin, and it is extremely difficult in the short time to calm down, it is caused sternly to patient
The appearance and spiritual influence of weight.
Utility model content
The purpose of the utility model is to overcome deficiency of the prior art in wound pain and in terms of inhibiting scar, provide one kind
With the moisture-preserving dressing for inhibiting scar hyperplasia effect.
To solve the above problems, the technical solution adopted in the utility model is:
A kind of analgesic dressing inhibiting scar, by antipruritic layer, silicon gel layer, electret layer, dressing layer, adhered layer and removing
Layer is constituted；The electret layer be it is inverted U-shaped, empty portions are filled by the silicon gel layer；The electret layer and silicon
The bottom end of gel layer is concordant, and is completely covered by the dressing layer.
Preferably, the electret layer is the polytetrafluoroethylene film accumulated through ion.
Preferably, the dressing layer absorbable medical diaphragm structure different by the degradation time with tissue inducing function
At.
Further, the raw material that prepare of the absorbable medical diaphragm are selected from absorbable polyurethane, can absorb and gather
The combination of one or both of ester, absorbable polyethers, absorbable polyaminoacid, absorbable carboxymethyl chitosan.
Preferably, the adhered layer is the medical pressure sensitive adhesive of low irritability.
Preferably, the peeling layer is that lattice draw zinc silicone oil paper.
Preferably, the antipruritic layer is the alginates pieces item for being adsorbed with asparagus juice, which is filled with setting and exists
In the hole of silicon gel layer bottom.
Preferably, adhered layer and dressing layer can be completely covered in the peeling layer.
The effect of aloe, which is embodied in, promotes wound healing, immunological regulation, anti-oxidant, antibacterial, antipruritic etc..In electret
The effect of storing electrostatic ionic charge inducing, physics swelling and pain relieving can be played.
The utility model inhibits scar hyperplasia and mechanism are as follows: on the one hand, when using degradation with tissue inducing function
Between different absorbable medical diaphragm creep shelf layer as the cell for pasting wound, during wound healing, cell is logical
It crosses diaphragm support structure of the invention slowly to creep growth, since degradation material degradation time is different, when causing tissue resorption
Between it is different, it is different that the creeping of surface of a wound cell grows uniformity coefficient, so as to form class dermatoglyph structure, prevents bulk scar
It generates.On the other hand, Silica hydrogel can limit the loss of skin surface moisture and increase the aquation of cuticula, and gel mould can be released
Releasing low molecule silicone oil, and 10 times of blood plasma of the oxygen solubility of silicone molecule and salt water, therefore aqueous cuticula leads to oxygen
Permeability is higher, and oxygen can be freely accessible to skin surface, the partial pressure of oxygen raising of epidermis and upper part of dermis.Hypoxemia can generate angiogenesis letter
Number, tissue growth is stimulated, raised partial pressure of oxygen can then close the signal of this stimulation and maintenance scar growth to inhibit scar
The growth of trace.
The utility model is with following the utility model has the advantages that 1) dressing layer can play effective nuring wound and inhibition scar increases
Double action；2) pain of wound can be incuded by the electrostatic daughter ion of electret layer and significantly be alleviated, thus
Improve the comfort of dressing nuring wound；3) dressing is applicable to due to the effect of having both antipruritic, antibacterial, analgesic and hemostasis
A plurality of types of wounds, and the dressing change frequency of nuring wound can be reduced, reduce the risk that secondary damage is caused to wound；4) dressing
Layer is made of absorbable material, and as dressing layer is gradually absorbed by human metabolism, wound gradually heals therewith, to dressing layer
After being completely absorbed wound healing, silicon gel layer can give full play to its aquation, to have tissue inducing function with front
The different absorbable medical dressing membrane collective effect of degradation time, limit the growth of scar, greatly so as to preferably support
Scar hyperplasia processed.
Detailed description of the invention
Fig. 1 is a kind of structural schematic diagram for the analgesic dressing for inhibiting scar of embodiment 1；
Fig. 2 is the plan view of silicon gel layer and electret layer bottom end in embodiment 1；
Description of symbols: 1, silicon gel layer, 2, antipruritic layer, 3, electret layer, 4, dressing layer, 5, adhered layer, 6, removing
Layer.
Specific embodiment
The utility model is further described with reference to the accompanying drawing.Following embodiment is only used for clearly illustrating this
The technical solution of utility model, and cannot be used as a limitation the limitation protection scope of the utility model.Those skilled in the art are come
It says, the omitting of some known structures and their instructions in the attached drawings are understandable.Positional relationship is described in attached drawing to be only used for showing
Example property explanation, should not be understood as the limitation to this patent.
Embodiment 1
As depicted in figs. 1 and 2, the analgesic dressing of a kind of inhibition scar of the utility model, structure is from inside to outside successively
It is made of silicon gel layer 1, antipruritic layer 2, electret layer 3, dressing layer 4, adhered layer 5 and peeling layer 6；The electret layer 3 is
Inverted U-shaped, empty portions are filled by silicon gel layer 1, and the bottom end of the electret layer 3 and silicon gel layer 1 is concordant, and by by can
The dressing layer 4 that the material that degradation absorbs is constituted is completely covered.Wherein, electret layer 3 is the polytetrafluoroethylene film accumulated through ion；
Dressing layer 4 is made of the different absorbable medical diaphragm of the degradation time with tissue inducing function, and the absorbable medical film
The raw material that prepare of piece are selected from absorbable polyurethane, absorbable polyester, absorbable polyethers, absorbable polyaminoacid, absorbable carboxylic
The combination of one or both of methyl chitosan；Adhered layer 5 is the medical pressure sensitive adhesive of low irritability；Peeling layer 6 is that lattice draw zinc silicon
Oilpaper；Antipruritic layer 2 is the alginates pieces item for being adsorbed with asparagus juice, which is filled in the hole of 1 bottom of silicon gel layer
In hole.In above layers, adhered layer 5 and dressing layer 4 can be completely covered in the peeling layer 6.
In use, opening outer packing, peeling layer 6 is torn, and the alignment wound of dressing layer 4 is dabbed and is fixed on skin around
On skin.
Obviously, the above embodiments of the present invention is used for the purpose of clearly demonstrating examples for clearly illustrating the present invention,
And it is not limitations of the embodiments of the present invention.For those of ordinary skill in the art, it is stated upper
It can also be made other variations or changes in different ways on the basis of bright.There is no need and unable to give all embodiments
With exhaustion.Any modifications, equivalent replacements, and improvements made within the spirit and principle of the present invention etc. should all include
Within the protection scope of the utility model claims.
Claims (7)
1. a kind of analgesic dressing for inhibiting scar, which is characterized in that by antipruritic layer, silicon gel layer, electret layer, dressing layer, glue
Paste layer and peeling layer are constituted；The electret layer be it is inverted U-shaped, empty portions are filled by the silicon gel layer；Described stays
The bottom end of polar body layer and silicon gel layer is concordant, and is completely covered by the dressing layer；
The adhered layer and dressing layer can be completely covered in the peeling layer.
2. a kind of analgesic dressing for inhibiting scar according to claim 1, which is characterized in that the electret layer is warp
The polytetrafluoroethylene film of ion accumulation.
3. a kind of analgesic dressing for inhibiting scar according to claim 1, which is characterized in that the dressing layer is by that can inhale
Medical diaphragm is received to constitute.
4. a kind of analgesic dressing for inhibiting scar according to claim 3, which is characterized in that the absorbable medical film
Piece is by absorbable polyurethane, absorbable polyester, absorbable polyethers, absorbable polyaminoacid, absorbable carboxymethyl chitosan
One or two composition.
5. a kind of analgesic dressing for inhibiting scar according to claim 1, which is characterized in that the adhered layer is low cause
The medical pressure sensitive adhesive of quick property.
6. a kind of analgesic dressing for inhibiting scar according to claim 1, which is characterized in that the peeling layer is lattice drawing
Zinc silicone oil paper.
7. a kind of analgesic dressing for inhibiting scar according to claim 1, which is characterized in that the antipruritic layer is absorption
There is the alginates pieces item of asparagus juice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821456715.8U CN209500067U (en) | 2018-09-06 | 2018-09-06 | A kind of analgesic dressing inhibiting scar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821456715.8U CN209500067U (en) | 2018-09-06 | 2018-09-06 | A kind of analgesic dressing inhibiting scar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209500067U true CN209500067U (en) | 2019-10-18 |
Family
ID=68185823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201821456715.8U Expired - Fee Related CN209500067U (en) | 2018-09-06 | 2018-09-06 | A kind of analgesic dressing inhibiting scar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209500067U (en) |
-
2018
- 2018-09-06 CN CN201821456715.8U patent/CN209500067U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7429996B2 (en) | Tissue treatment devices containing microstructures | |
| CN110935056A (en) | Preparation method of alginate dressing with high hygroscopicity | |
| CN107412842B (en) | Preparation method of alginate wound dressing with thrombin | |
| CN209500067U (en) | A kind of analgesic dressing inhibiting scar | |
| CN1634606A (en) | Externally applied acesodyne electret film for medical use and method for manufacturing the same | |
| CN209450778U (en) | A kind of compound dressing inhibiting scar | |
| CN208808841U (en) | A kind of compound wire side medical dressing | |
| CN210019926U (en) | Absorbable and degradable dressing for inhibiting scars | |
| CN209450779U (en) | A kind of moisturizing dressing inhibiting scar | |
| CN206792706U (en) | A kind of external application bleeding-stopping dressing | |
| CN213431013U (en) | External dressing for II-degree burn wound of limbs | |
| CN211433138U (en) | Emergency department hemostasis bandage care implement | |
| CN114305869A (en) | Medical auxiliary material with sterilization and nourishing effects | |
| CN208114705U (en) | A kind of activated carbon fibre dressing with pain-relieving functions | |
| CN207871271U (en) | A kind of medical silicone gel scar plaster | |
| CN211095261U (en) | Lavender band-aid | |
| CN208552237U (en) | A kind of compound alginates bandage | |
| Swanson | Modern dressings and technologies | |
| CN209751374U (en) | Moisturizing dressing for inhibiting scar hyperplasia | |
| CN209237039U (en) | A kind of dedicated bandage of fixed remaining needle | |
| CN208591334U (en) | Honey sterilizes bandage | |
| CN209187209U (en) | A kind of medical dressing inhibiting scar | |
| CN212756628U (en) | Soluble hemostatic gauze | |
| Alves et al. | Clinical experiences of using a cellulose dressing on burns and donor site wounds | |
| CN217611709U (en) | Novel dressing for wound repair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191018 |